The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…
Read More
Insights from Millennium Technology Prize Panel Illuminate European Biotech Strengths and Strategic Imperatives
A recent high-level panel discussion, convened by the Technology Academy Finland (TAF) at the Finnish Ambassador’s residence in London, brought…
Read More
European Biotech Leaders Chart Course for Innovation, Urge Risk-Taking and Long-Term Commitment at Millennium Technology Prize Panel
A recent high-level panel discussion, convened by the Technology Academy Finland (TAF) and hosted at the residence of the Finnish…
Read More
Scientists Map Ultra-Fast Plasma Formation with Femtosecond Precision at European XFEL
The pursuit of clean, limitless energy through nuclear fusion and the understanding of the most violent phenomena in the universe…
Read More
Tirzepatide Shows Promising Adjunct Benefits in Type 1 Diabetes Management, Meta-Analysis Presented at European Congress on Obesity Suggests
The burgeoning field of GLP-1 receptor agonists, celebrated for their transformative impact on obesity and type 2 diabetes (T2D) management,…
Read More
Capturing the Chaos: HZDR Researchers Unveil the Picosecond Evolution of Laser-Induced Plasma at European XFEL
In the realm of high-energy density physics, the transition of solid matter into plasma occurs with such violent speed and…
Read More
Loneliness Linked to Lower Baseline Memory in Older Adults but Does Not Accelerate Long-Term Cognitive Decline According to Large European Study
A comprehensive longitudinal study involving more than 10,000 participants across Europe has revealed a complex relationship between subjective feelings of…
Read More
Novartis Secures Dual Regulatory Milestones: European Approval for Rhapsido and WHO Prequalification for Coartem Baby
Novartis has achieved significant regulatory successes on two fronts, with its oral therapy Rhapsido (remibrutinib) receiving marketing authorisation from the…
Read More
New Qulipta Study Data Bolsters Case Against Restrictive European Reimbursement Policies
New clinical trial results presented by AbbVie are poised to significantly influence the landscape of migraine prevention in Europe, providing…
Read More
Jeito Capital’s Second Fund Closes Above Target, Bolstering European Biopharma Investment to Over €1.6 Billion
Global independent private equity fund Jeito Capital has achieved a significant milestone in European biopharma investment with the successful closure…
Read MoreYOU MAY HAVE MISSED
